Correlation Between Jupiter Neurosciences, and Dogwood Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jupiter Neurosciences, and Dogwood Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jupiter Neurosciences, and Dogwood Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jupiter Neurosciences, Common and Dogwood Therapeutics,, you can compare the effects of market volatilities on Jupiter Neurosciences, and Dogwood Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jupiter Neurosciences, with a short position of Dogwood Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jupiter Neurosciences, and Dogwood Therapeutics,.

Diversification Opportunities for Jupiter Neurosciences, and Dogwood Therapeutics,

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Jupiter and Dogwood is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Jupiter Neurosciences, Common and Dogwood Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dogwood Therapeutics, and Jupiter Neurosciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jupiter Neurosciences, Common are associated (or correlated) with Dogwood Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dogwood Therapeutics, has no effect on the direction of Jupiter Neurosciences, i.e., Jupiter Neurosciences, and Dogwood Therapeutics, go up and down completely randomly.

Pair Corralation between Jupiter Neurosciences, and Dogwood Therapeutics,

Given the investment horizon of 90 days Jupiter Neurosciences, Common is expected to generate 1.66 times more return on investment than Dogwood Therapeutics,. However, Jupiter Neurosciences, is 1.66 times more volatile than Dogwood Therapeutics,. It trades about 0.32 of its potential returns per unit of risk. Dogwood Therapeutics, is currently generating about 0.03 per unit of risk. If you would invest  549.00  in Jupiter Neurosciences, Common on September 24, 2024 and sell it today you would earn a total of  424.00  from holding Jupiter Neurosciences, Common or generate 77.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy3.01%
ValuesDaily Returns

Jupiter Neurosciences, Common  vs.  Dogwood Therapeutics,

 Performance 
       Timeline  
Jupiter Neurosciences, 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Jupiter Neurosciences, Common are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Jupiter Neurosciences, unveiled solid returns over the last few months and may actually be approaching a breakup point.
Dogwood Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dogwood Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Jupiter Neurosciences, and Dogwood Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jupiter Neurosciences, and Dogwood Therapeutics,

The main advantage of trading using opposite Jupiter Neurosciences, and Dogwood Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jupiter Neurosciences, position performs unexpectedly, Dogwood Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dogwood Therapeutics, will offset losses from the drop in Dogwood Therapeutics,'s long position.
The idea behind Jupiter Neurosciences, Common and Dogwood Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamental Analysis
View fundamental data based on most recent published financial statements